China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Revenue

China SXT Pharmaceuticals had revenue of $939.58K in the half year ending September 30, 2023, a decrease of -8.57%. This brings the company's revenue in the last twelve months to $1.70M, down -38.81% year-over-year. In the fiscal year ending March 31, 2023, China SXT Pharmaceuticals had annual revenue of $1.97M, down -24.23%.

• Revenue (ttm): $1.70M
• Revenue Growth: -38.81%
• P/S Ratio: 30.17
• Revenue / Employee: $384
• Employees: 78
• Market Cap: 902.54K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2023	1.97M	-630.60K	-24.23%
Mar 31, 2022	2.60M	-2.18M	-45.53%
Mar 31, 2021	4.78M	-384.70K	-7.45%
Mar 31, 2020	5.16M	-1.85M	-26.38%
Mar 31, 2019	7.01M	-7.22K	-0.10%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.